These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 3958352)
41. Long-term multicenter experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias. The Guardian Multicenter Investigators Group. Saksena S; Poczobutt-Johanos M; Castle LW; Fogoros RN; Alpert BL; Kron J; Pacifico A; Griffin J; Ruskin JN; Kehoe RF J Am Coll Cardiol; 1992 Mar; 19(3):490-9. PubMed ID: 1537999 [TBL] [Abstract][Full Text] [Related]
42. Initial clinical experience with the pacemaker-cardioverter-defibrillator. Yee R; Klein GJ; Guiraudon GM; Jones DL; Sharma AD; Norris C Can J Cardiol; 1990 May; 6(4):147-56. PubMed ID: 2344560 [TBL] [Abstract][Full Text] [Related]
43. Use of the automatic implantable cardioverter-defibrillator in the treatment of malignant ventricular tachyarrhythmias. Mirowski M; Reid PR; Mower MM; Watkins L; Platia EV; Griffith LS; Juanteguy JM Herz; 1984 Apr; 9(2):83-9. PubMed ID: 6714918 [TBL] [Abstract][Full Text] [Related]
45. Reversible failure to sense ventricular tachycardia early after surgical implantation of the automatic implantable cardioverter-defibrillator. Glicksman FL; Zaman L; Huikuri HV; Castellanos A; Myerburg RJ Am J Cardiol; 1988 Oct; 62(10 Pt 1):833-4. PubMed ID: 3421189 [No Abstract] [Full Text] [Related]
46. A permanent transvenous lead system for an implantable pacemaker cardioverter-defibrillator. Nonthoracotomy approach to implantation. Yee R; Klein GJ; Leitch JW; Guiraudon GM; Guiraudon CM; Jones DL; Norris C Circulation; 1992 Jan; 85(1):196-204. PubMed ID: 1728450 [TBL] [Abstract][Full Text] [Related]
47. Automatic implantable cardioverter-defibrillator implantation without thoracotomy using an endocardial and submuscular patch system. McCowan R; Maloney J; Wilkoff B; Simmons T; Khoury D; McAlister H; Morant V; Castle L J Am Coll Cardiol; 1991 Feb; 17(2):415-21. PubMed ID: 1991899 [TBL] [Abstract][Full Text] [Related]
48. Hybrid therapy of atrial fibrillation. Santini M; Pignalberi C; Ricci R; Calò L Ital Heart J; 2002 Oct; 3(10):571-8. PubMed ID: 12478814 [TBL] [Abstract][Full Text] [Related]
49. Automatic implantable cardioverter-defibrillator: is early implantation cost-effective? O'Donoghue S; Platia EV; Brooks-Robinson S; Mispireta L J Am Coll Cardiol; 1990 Nov; 16(5):1258-63. PubMed ID: 2121811 [TBL] [Abstract][Full Text] [Related]
50. Tachycardia sensing failure of an implantable cardioverter defibrillator in a patient with hypertrophic cardiomyopathy. Grubb BP; Durzinsky D; Temesy-Armos P; Hahn H; Elliott L Pacing Clin Electrophysiol; 1992 Jun; 15(6):845-8. PubMed ID: 1376894 [TBL] [Abstract][Full Text] [Related]
51. Indications for dual-chamber (DDD) pacing in implantable cardioverter-defibrillator patients. Santini M; Ansalone G; Auriti A; Magris B; Pandozi C; Altamura G Am J Cardiol; 1996 Sep; 78(5A):116-8. PubMed ID: 8820847 [TBL] [Abstract][Full Text] [Related]
52. [From implantable cardioverter-defibrillator to cardiac resynchronization therapy with the use of epicardial left ventricular lead. The evolution of the treatment of post inflammatory heart failure--a case report]. Gepner K; Sterliński M; Przybylski A; Maciag A; Kołsut P; Szwed H Kardiol Pol; 2006 Oct; 64(10):1113-7. PubMed ID: 17089244 [TBL] [Abstract][Full Text] [Related]
53. The automatic implantable cardioverter-defibrillator: efficacy, complications and survival in patients with malignant ventricular arrhythmias. Kelly PA; Cannom DS; Garan H; Mirabal GS; Harthorne JW; Hurvitz RJ; Vlahakes GJ; Jacobs ML; Ilvento JP; Buckley MJ J Am Coll Cardiol; 1988 Jun; 11(6):1278-86. PubMed ID: 3367002 [TBL] [Abstract][Full Text] [Related]